about
Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study GroupVHL c.505 T>C mutation confers a high age related penetrance but no increased overall mortalityBiological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease.Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau diseaseDevelopmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau diseaseA case of von Hippel-Lindau disease with exudative maculopathy.Overexpression and activation of epidermal growth factor receptor in hemangioblastomas.Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells.Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease.A case of carotid body paraganglioma and haemangioblastoma of the spinal cord in a patient with the N131K missense mutation in the VHL gene.The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas.Clinical and molecular features associated with cystic visceral lesions in von hippel-lindau diseaseDevelopment of Database and Genomic Medicine for von Hippel-Lindau Disease in JapanMutations in the von hippel-lindau tumour suppressor gene in central nervous system hemangioblastomasDeafness due to bilateral endolymphatic sac tumours in a case of von Hippel-Lindau syndrome.Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors.Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery.Stereotactic radiosurgical treatment of cranial and spinal hemangioblastomas.Clinical features of patients bearing central nervous system hemangioblastoma in von Hippel-Lindau disease.Central nervous system hemangioblastoma and von Hippel-Lindau syndrome: a familial presentation.Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation
P2860
Q28277782-2B8BF623-C599-4C3D-81CE-F243EDE32F6DQ28345120-98138BC7-D2B4-4D45-B0D2-1468ABD443A5Q30278444-B5AA4B88-5A22-4633-902D-EF6958B5D3BFQ30360730-C80231C7-BC7E-4896-B8B5-C68B4643B48EQ30430557-18278EB3-697F-4AB4-8581-5C2352AED65CQ33645424-11A08741-BA27-4E8E-A5E8-9E4155ED3368Q34083790-EC65DC57-E574-41B6-8492-F89950041110Q34536583-831DDF58-C0FA-45AC-966E-E276DDE6DF54Q34660697-304C8BD0-9898-445A-883D-5E422928501AQ34975938-7229FD93-624A-419A-897D-703857FC90ACQ35454776-C1797567-C1B6-43CF-A925-45448BD7534BQ35462032-76E0405C-AF99-4C46-AC91-453A845F166CQ35745668-94131A4C-0070-4DE4-B70C-06D2AB4898A4Q36247800-336AE722-816D-4064-A5B7-C2083F22ED9AQ37686322-5E8489B5-1CFB-4737-B290-6774268E5A6CQ38449441-2CB27DF4-2CC5-4307-8F48-3B21E74B6FF1Q41354954-787B6428-59E9-4514-8FF0-1370A1A5568EQ42827339-C1052B10-8C5F-4729-9EB3-542945DA0647Q46558430-4C57EB2C-74A5-40D9-BAF7-7A74D1C5AC77Q46748718-D5A8C65A-DFDE-4696-9937-05C03078315DQ46800577-9A0DD025-A8F9-4A68-B6ED-B738C0403121Q48453908-883BC3D5-FA3F-4C49-8B64-D42D1552D793Q57631389-727C3DAA-008A-4F24-9199-BE7AD89C0948
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Von Hippel-Lindau syndrome.
@en
type
label
Von Hippel-Lindau syndrome.
@en
prefLabel
Von Hippel-Lindau syndrome.
@en
P2093
P2860
P1433
P1476
Von Hippel-Lindau syndrome.
@en
P2093
P2860
P304
P356
10.1111/J.1750-3639.1995.TB00592.X
P577
1995-04-01T00:00:00Z